‌

US Patent 8198400 Vaccine for modulating between T1 and T2 immune responses

Patent 8198400 was granted and assigned to Oncothyreon on June, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Oncothyreon

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8198400

Patent Inventor Names

B. Michael Longenecker0

Wladyslaw A. Budzynski0

R. Rao Koganty0

Mark J. Krantz0

Date of Patent

June 12, 2012

Patent Application Number

10106876

Date Filed

March 27, 2002

Patent Primary Examiner

‌

Agnieszka Boesen

Patent abstract

The present invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8198400 Vaccine for modulating between T1 and T2 immune responses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API